These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2616352)

  • 1. The effect of sucralfate pretreatment on the pharmacokinetics of ciprofloxacin.
    Nix DE; Watson WA; Handy L; Frost RW; Rescott DL; Goldstein HR
    Pharmacotherapy; 1989; 9(6):377-80. PubMed ID: 2616352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined use of ciprofloxacin and sucralfate.
    Van Slooten AD; Nix DE; Wilton JH; Love JH; Spivey JM; Goldstein HR
    DICP; 1991 Jun; 25(6):578-82. PubMed ID: 1877263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sucralfate significantly reduces ciprofloxacin concentrations in serum.
    Garrelts JC; Godley PJ; Peterie JD; Gerlach EH; Yakshe CC
    Antimicrob Agents Chemother; 1990 May; 34(5):931-3. PubMed ID: 2360833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Sucralfate on the Relative Bioavailability of Enrofloxacin and Ciprofloxacin in Healthy Fed Dogs.
    KuKanich K; KuKanich B; Guess S; Heinrich E
    J Vet Intern Med; 2016; 30(1):108-15. PubMed ID: 26651022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sucralfate on pharmacokinetics of fleroxacin in healthy volunteers.
    Lubowski TJ; Nightingale CH; Sweeney K; Quintiliani R
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2758-60. PubMed ID: 1482143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of staggered dosing of sucralfate on oral bioavailability of sparfloxacin.
    Kamberi M; Nakashima H; Ogawa K; Oda N; Nakano S
    Br J Clin Pharmacol; 2000 Feb; 49(2):98-103. PubMed ID: 10671902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sucralfate reduces the gastrointestinal absorption of norfloxacin.
    Parpia SH; Nix DE; Hejmanowski LG; Goldstein HR; Wilton JH; Schentag JJ
    Antimicrob Agents Chemother; 1989 Jan; 33(1):99-102. PubMed ID: 2712548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sucralfate on absorption of norfloxacin and ofloxacin.
    Lehto P; Kivistö KT
    Antimicrob Agents Chemother; 1994 Feb; 38(2):248-51. PubMed ID: 8192452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sucralfate on theophylline absorption in healthy volunteers.
    Cantral KA; Schaaf LJ; Jungnickel PW; Monsour HP
    Clin Pharm; 1988 Jan; 7(1):58-61. PubMed ID: 3345643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of effect of sucralfate on prednisone bioavailability.
    Gambertoglio JG; Romac DR; Yong CL; Birnbaum J; Lizak P; Amend WJ
    Am J Gastroenterol; 1987 Jan; 82(1):42-5. PubMed ID: 3799579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sucralfate on the absorption and pharmacokinetics of chlorpropamide.
    Letendre PW; Carlson JD; Seifert RD; Dietz AJ; Dimmit D
    J Clin Pharmacol; 1986; 26(8):622-5. PubMed ID: 3793953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a Kampo preparation, byakkokaninjinto, on pharmacokinetics of ciprofloxacin and tetracycline.
    Ohnishi M; Hitoshi K; Katoh M; Nadai M; Abe F; Kurono S; Saito H; Haniuda M; Hasegawa T
    Biol Pharm Bull; 2009 Jun; 32(6):1080-4. PubMed ID: 19483319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference of dairy products with the absorption of ciprofloxacin.
    Neuvonen PJ; Kivistö KT; Lehto P
    Clin Pharmacol Ther; 1991 Nov; 50(5 Pt 1):498-502. PubMed ID: 1934862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on quinolone drug interactions.
    Hulisz D; Miller K
    Am Pharm; 1990 Sep; NS30(9):34-6. PubMed ID: 2220561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ranitidine and sucralfate on ketoconazole bioavailability.
    Piscitelli SC; Goss TF; Wilton JH; D'Andrea DT; Goldstein H; Schentag JJ
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1765-71. PubMed ID: 1952845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of fecal Enterobacteriaceae by intravenous ciprofloxacin is not inhibited by concomitant sucralfate--a microbiological and pharmacokinetic study in patients.
    Krueger WA; Ruckdeschel G; Unertl K
    Infection; 1999; 27(6):335-40. PubMed ID: 10624593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sucralfate on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in healthy volunteers.
    Stass H; Schühly U; Möller JG; Delesen H
    Clin Pharmacokinet; 2001; 40 Suppl 1():49-55. PubMed ID: 11352442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sevelamer hydrochloride and calcium acetate on the oral bioavailability of ciprofloxacin.
    Kays MB; Overholser BR; Mueller BA; Moe SM; Sowinski KM
    Am J Kidney Dis; 2003 Dec; 42(6):1253-9. PubMed ID: 14655198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate.
    Zix JA; Geerdes-Fenge HF; Rau M; Vöckler J; Borner K; Koeppe P; Lode H
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1668-72. PubMed ID: 9257738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of intravenously administered ciprofloxacin on aerobic intestinal microflora and fecal drug levels when administered simultaneously with sucralfate.
    Krueger WA; Ruckdeschel G; Unertl K
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1725-30. PubMed ID: 9257749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.